DDOG vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Datadog, Inc. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-15.
Datadog, Inc. · Technology
$261.09
+45.0% upside to fair value
Grade B
High Quality
VS
Johnson & Johnson · Healthcare
$253.85
-21.7% upside to fair value
Grade D
High Quality
QuantHub Verdict
DDOG has more upside to fair value
(+45.0%).
JNJ trades at a lower forward P/E
(29.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DDOG |
JNJ |
| Current Price |
$261.09 |
$253.85 |
| Fair Value Estimate |
$378.58 |
$198.76 |
| Upside to Fair Value |
+45.0%
|
-21.7%
|
| Market Cap |
$92.9B |
$611.1B |
| Forward P/E |
678.5x
|
29.3x
|
| EV / EBITDA |
410.4x
|
19.2x
|
| Price / Sales |
25.3x
|
6.3x
|
| Price / FCF |
86.1x
|
34.3x
|
| Revenue Growth YoY |
+32.2%
|
+9.9%
|
| Gross Margin |
79.9%
|
69.1%
|
| Operating Margin |
-0.7%
|
26.9%
|
| Return on Equity |
3.8%
|
26.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.16%
|
2.91%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Datadog, Inc. is a leading provider of cloud-scale monitoring and analytics software for developers, IT operations teams, and business users in the technology sector. The company exhibits strong business quality with a durable competitive moat supported by high gross margins of 79.9% and rapid revenue growth of 32.2% in the most recent quarter. Despite this, the stock trades at a very high valuat…
Johnson & Johnson is a leading healthcare conglomerate operating primarily in the drug manufacturing sector, known for its durable competitive moat supported by strong brand recognition and intangible assets. The company exhibits high business quality with a 26.3% return on equity and robust gross and net margins of 69.1% and 21.8%, respectively. However, earnings have faced significant pressure,…
Accumulation Zones
| Metric |
DDOG |
JNJ |
| Zone Low |
$283.94 |
$149.07 |
| Zone High |
$321.79 |
$168.95 |
| In Buy Zone? |
Yes
|
No
|